TruBridge (TBRG) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 revenue was $84.7 million, nearly flat year-over-year, with RCM revenue growth offsetting EHR declines; H1 2024 revenue was $168.0 million, down 2% year-over-year, mainly due to lower EHR segment revenues and the AHT sale, partially offset by Viewgol acquisition growth.
Net loss for H1 2024 was $7.6 million, compared to net income of $0.2 million in the prior year, driven by higher severance, non-recurring charges, interest expense, cloud migration costs, and increased amortization; Q2 GAAP net loss was $5.0 million.
Bookings momentum continued, with Q2 bookings at $23.3 million, up 11% year-over-year, and over 90% of projected 2024 revenue under contract.
Integrated nTrust solution and Viewgol acquisition drove new client growth and operational improvements, with cross-selling efforts yielding $7 million in signed contracts and Viewgol contributing $9.9 million in H1 revenue.
A material weakness in internal controls over financial reporting was identified and is being remediated.
Financial highlights
RCM revenues rose 11% year-over-year to $107.1 million for H1 2024, with Viewgol contributing $9.9 million; EHR revenues fell 18% to $60.8 million.
Adjusted EBITDA for Q2 was $12.6 million (margin 14.8%), up 12% year-over-year and 33% sequentially; H1 adjusted EBITDA was $22.0 million, down from $25.9 million in the prior year.
Operating cash flow was $13.8 million in Q2 and $11.7 million for H1, up from $10.2 million year-over-year.
Gross margin improved to 48.8% in Q2 and 49% for H1, up from 48% in the prior year.
Net loss per share was $(0.51) for H1 2024; Q2 non-GAAP EPS was $0.16, down from $0.40.
Outlook and guidance
Q3 2024 revenue expected between $82 million and $85 million; adjusted EBITDA between $11.5 million and $13.5 million.
Full-year 2024 revenue guidance reiterated at $330 million to $340 million, with adjusted EBITDA between $45 million and $50 million.
Management expects continued EHR revenue pressure due to Centriq sunset and SaaS migration, but RCM segment to benefit from Viewgol integration and cross-selling.
Latest events from TruBridge
- Demand, bookings, and margins are rising as offshoring and automation drive operational gains.TBRG
Stephens 26th Annual Investment Conference | NASH20248 Jul 2026 - Merger and executive compensation proposals both passed by majority stockholder vote.TBRG
EGM 20267 Jul 2026 - Shareholders to vote on a premium cash merger with IKS; board and major holders support the deal.TBRG
Proxy filing4 Jun 2026 - Shareholders to vote on cash merger at $26.25/share; board and major holders support the deal.TBRG
Proxy filing21 May 2026 - Q1 2026 saw $86.3M revenue, rising non-GAAP net income, and a pending IKS acquisition.TBRG
Q1 20268 May 2026 - TruBridge's acquisition by IKS Health targets improved healthcare access and operational stability.TBRG
Proxy filing23 Apr 2026 - IKS Health to acquire TruBridge for $557M, creating a leading healthcare solutions platform.TBRG
Proxy filing23 Apr 2026 - TruBridge will be acquired by IKS for $26.25 per share in cash, pending approvals.TBRG
Proxy filing23 Apr 2026 - Margin gains, strong recurring revenue, and GAAP profitability marked the year.TBRG
Q4 202531 Mar 2026